Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/10857
Title: | Investigation of the effect of astaxanthin on alveolar bone loss in experimental periodontitis | Authors: | Balci Yuce, H. Lektemur Alpan, Aysan Gevrek, F. Toker, H. |
Keywords: | antioxidants astaxanthin experimental periodontitis inducible nitric oxide synthase tartrate-resistant acid phosphatase antioxidant Bax protein, rat bone morphogenetic protein 2 nitric oxide synthase osteocalcin protein Bax xanthophyll alveolar bone loss animal cell count disease model drug effect metabolism osteoblast periodontitis Wistar rat Alveolar Bone Loss Animals Antioxidants bcl-2-Associated X Protein Bone Morphogenetic Protein 2 Cell Count Disease Models, Animal Nitric Oxide Synthase Osteoblasts Osteocalcin Periodontitis Rats, Wistar Xanthophylls |
Publisher: | Blackwell Munksgaard | Abstract: | Background and Objective: Astaxanthin is a keto-carotenoid that has a strong antioxidant effect. The purpose of this study was to evaluate the effects of astaxanthin on alveolar bone loss and histopathological changes in ligature-induced periodontitis in rats. Material and methods: Wistar rats were divided into four experimental groups: non-ligated (C, n = 6); ligature only (L, n = 6); ligature and astaxanthin (1 mg/kg/day astaxanthin, AS1 group, n = 8); ligature and astaxanthin (5 mg/kg/day astaxanthin, AS5 group, n = 8). Silk ligatures were placed at the gingival margin of lower first molars of the mandibular quadrant. The study duration was 11 days and the animals were killed at the end of this period. Changes in alveolar bone levels were clinically measured and tissues were immunohistochemically examined, osteocalcin, bone morphogenic protein-2, inducible nitric oxide synthase, Bax and bcl-2 levels in alveolar bone and tartrate-resistant acid phosphatase-positive osteoclast cells, osteoblast and inflammatory cell counts were determined. Results: Alveolar bone loss was highest in the L group and the differences among the L, AS1 and AS5 groups were also significant (P <.05). Both doses of astaxanthin decreased tartrate-resistant acid phosphatase-positive+ osteoclast cell and increased osteoblast cell counts (P <.05). The inflammation in the L group was also higher than those of the C and AS1 groups were (P <.05) indicating the anti-inflammatory effect of astaxanthin. Although inducible nitric oxide synthase, osteocalcin, bone morphogenic protein-2 and bax staining percentages were all highest in the AS5 group and bcl-2 staining percentage was highest in the AS1 group, values were close to each other (P >.05). Conclusion: Within the limits of this study, it can be suggested that astaxanthin administration may reduce alveolar bone loss by increasing osteoblastic activity and decrease osteoclastic activity in experimental periodontitis model. © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd | URI: | https://hdl.handle.net/11499/10857 https://doi.org/10.1111/jre.12497 |
ISSN: | 0022-3484 |
Appears in Collections: | Diş Hekimliği Fakültesi Koleksiyonu PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
SCOPUSTM
Citations
34
checked on Dec 14, 2024
WEB OF SCIENCETM
Citations
32
checked on Dec 18, 2024
Page view(s)
36
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.